State of the Science Update and What to Expect- Part 1 (WGs 1, 3, 4)
Speaker(s): Working Group Members
Did you miss the August 4th Wednesday Webinar? If so click here to listen to Dr. Margaret Ragni, Dr. Maureen Baldwin, and…
State of the Science Update and What to Expect - Part 2 (WGs 2, 4 6)
Speaker(s): Working Group Members
Did you miss the August 11th Wednesday Webinar? If so click here to listen to the State of the Science working group members…
Anti-TFPI for the Treatment of People with Hemophilia
Speaker(s): Michael Wang, MD; Beth Warren, MD
Did you miss the September 8th Wednesday Webinar? If so click here to listen to Dr Beth Warren and Dr Michael Wang from the…
Is Pharmacokinetic Assessment a Step Towards Precision Medicine?
Speaker(s): Leonard Valentino, MD
Did you miss the September 22nd Wednesday Webinar? If so click here to join our President and CEO Dr. Len Valentino discuss the…
Shared decision making (SDM), the concept by which patients and healthcare providers work closely together to arrive at personalized treatment-related decisions, can have significant positive impacts for individuals with hemophilia. It fosters a…
NHF is very pleased to announce that the Kevin Child Scholarship (KCS) application deadline has been set for August 2, 2021! The scholarship is named in tribute to Kevin Child, who died of AIDS in 1989, shortly before graduating from college. It is…
The U.S. Food and Drug Administration (FDA) has placed a clinical hold on Sigilon Therapeutics’ phase 1/2 study of SIG-001 in patients with severe or moderately severe hemophilia A.
SIG-001 is a cell-based therapy, designed to carry significant…